FDA's Vaccines and Related Biological Products Advisory Committee votes on composition of 2016-2017 [43 KB, 4 pages]
"On March 4, 2016 at 8:30 a.m. Eastern Standard Time (EST), the Acting Chair, Dr. Ruth Lynfield, called to order the 142nd Meeting of the Vaccines and Related Biological Products Advisory Committee to discuss the topic "Strain Selection for the Influenza Virus Vaccines for the 2016-2017 Influenza Season". The meeting was held in an open session. The Chair invited the members, temporary members, and participants seated at the table to introduce themselves."
|Download Full PDF|